US2011098818A1PendingUtilityA1

Radiolucent spinal fusion cage

Individually held — no corporate assignee on recordPriority: May 1, 2001Filed: May 10, 2010Published: Apr 28, 2011
Est. expiryMay 1, 2021(expired)· nominal 20-yr term from priority
A61F 2/4603A61F 2002/30593A61F 2/447A61F 2002/30153A61F 2230/0058A61F 2002/3082A61F 2002/3028A61L 27/3608A61F 2002/30158A61F 2230/0019A61L 27/56A61F 2002/30235A61L 27/365A61L 27/30A61F 2002/30881A61L 27/3804A61F 2002/30616A61L 27/32A61L 27/3847A61F 2/446A61F 2230/0069A61F 2002/3092A61F 2002/30968A61F 2310/0097A61F 2002/30774A61F 2/30767A61F 2310/00796A61F 2230/0026A61L 2430/38A61F 2250/0019A61F 2230/0063A61F 2002/30166A61F 2002/30266A61F 2002/30179A61F 2002/30064A61F 2002/3085A61F 2002/30677A61F 2310/00928A61F 2002/30224A61F 2230/0082A61F 2002/30789A61F 2250/0023A61F 2002/30733A61F 2310/00203A61F 2/4611A61L 2430/02A61F 2/442A61F 2002/4648A61F 2220/0025A61F 2002/30891A61F 2002/30261A61F 2230/0028A61F 2002/30896A61F 2002/2835A61L 27/10A61F 2002/30329A61F 2002/4629A61F 2002/30016A61F 2002/4627A61F 2002/30822A61F 2002/30827A61F 2002/30777A61F 2310/00976A61F 2002/30011A61F 2310/00239A61F 2002/30892A61L 27/3834
48
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An improved bone graft is provided for human implantation, particularly such as a spinal fusion cage for implantation into the inter-vertebral space between two adjacent vertebrae. The improved spinal fusion cage includes a substrate block of high strength biocompatible material having a selected size and shape to fit the anatomical space, and a controlled porosity analogous to natural bone. The substrate block may be coated with a bio-active surface coating material such as hydroxyapatite or a calcium phosphate to promote bone ingrowth and enhanced bone fusion. Upon implantation, the fusion cage provides a spacer element having a desired combination of mechanical strength together with osteoconductivity and osteoinductivity to promote bone ingrowth and fusion, as well as radiolucency for facilitated post-operative monitoring. The fusion cage may additionally carry one or more natural or synthetic therapeutic agents for further promoting bone ingrowth and fusion.

Claims

exact text as granted — not AI-modified
1 - 84 . (canceled) 
     
     
         85 . An implantable prosthetic component for ingrowth attachment with adjacent spinal tissue, comprising:
 a substrate block consisting essentially of a ceramic material, and having surfaces for ingrowth attachment with adjacent spinal tissue, the substrate block comprising:
 a top surface configured for ingrowth attachment with a first vertebral body; 
 a bottom surface configured for ingrowth attachment with a second vertebral body adjacent to the first vertebral body; and 
 a substantially radiolucent body visible under X-ray imaging, but having a density allowing for passage of X-rays through the ceramic material of the body under medial-lateral X-ray imaging thus facilitating post-operative assessment of bone ingrowth from the first and second vertebral bodies into the body through the top and bottom surfaces. 
   
     
     
         86 . The implantable prosthetic component of  claim 85  wherein said substrate block includes a first, lower porosity region and a second, higher porosity region, said second region including said top and bottom exterior surfaces for ingrowth attachment with said first and second vertebral bodies. 
     
     
         87 . The implantable prosthetic component of  claim 86  wherein said second region has a porosity ranging from about 30% to about 80% by volume. 
     
     
         88 . The implantable prosthetic component of  claim 87  wherein the pore sizes in the second region range from about 100 microns to about 500 microns. 
     
     
         89 . The implantable prosthetic component of  claim 86  wherein said first region has a porosity of less than about 5% by volume. 
     
     
         90 . The implantable prosthetic component of  claim 86  wherein said first region has a relatively high strength corresponding substantially with cortical bone, and wherein said second region has a porosity corresponding substantially with cancellous bone.

Join the waitlist — get patent alerts

Track US2011098818A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.